$MMSI

Merit Medical Systems to Announce Second Quarter 2026 Results on July 30, 2026

Merit Medical Systems (NASDAQ: MMSI) said it will report second-quarter 2026 results for the quarter ended June 30, 2026 after the market close on July 30, 2026. The company will host an investor conference call that day at 4:30 p.m. ET, with a live webcast and slide deck available on its website.

Original reporting
Published Jul 2, 2026, 9:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 2, 2026, 9:29 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Merit Medical Systems to Announce Second Quarter 2026 Results on July 30, 2026 — source image
Decision brief

The 30-second read

$MMSINeutralMed
01

Why it matters

The primary tradable element is event timing: after-close earnings and same-day call can drive pre-positioning, intraday hedging, and post-release repricing.

02

Market read

Provides a concrete earnings-event calendar for MMSI, enabling traders to plan around the after-close release and call.

03

What to watch

Implied volatility and options positioning may matter more than the announcement itself; actual direction will hinge on Q2 results, margins, and any updated guidance not included here.

Relevance 4/10Novelty 3/10Timing: Ahead of the July 30, 2026 after-close Q2 2026 earnings release and 4:30 p.m. ET call.

Background

Merit Medical Systems (MMSI) scheduled its quarter ended June 30, 2026 results for release after the close on July 30, 2026, followed by an investor conference call.

Company-level read

Ticker impact

$MMSINeutralMedium confidence
Context

Merit Medical Systems will release Q2 2026 results after the close on July 30, 2026, with an investor call at 4:30 p.m. ET.

Expected impact

Moderate volatility risk into the July 30 after-close earnings window; direction depends on the forthcoming results.

Evidence & confidence

The article discloses only timing (release date/time) and no financial figures, guidance, or new operational developments.

Market effects

Limited—only a single-company earnings calendar item; no sector-wide datapoint or read-across.

Limited—US-listed healthcare device company event timing; no broader regional macro linkage.

Limited—no international regulatory/product developments mentioned.

Counterpoint

Because the release timing is already the key detail and no new fundamentals are disclosed, the market may treat it as routine and trade mainly on expectations rather than this PR.

Key entities

  • Merit Medical Systems, Inc.

    NASDAQ-listed medical device company releasing Q2 2026 results on July 30, 2026 after the close.

  • Investor conference call

    Scheduled for July 30, 2026 at 4:30 p.m. Eastern (3:30 p.m. Central).

Related articles

$MMSIMedAI 8/10

Merit Medical (MMSI) Q2 2026 Earnings Call Transcript

Merit Medical Systems (MMSI) reported Q2 2026 revenue of $418.8 million, up 10% GAAP, and non-GAAP EPS of $1.19. Non-GAAP operating margin was 22.6% and free cash flow $51.9 million. The company raised 2026 revenue guidance to $1.631B-$1.643B and non-GAAP EPS to $4.25-$4.35, and guided Q3 revenue to $408M-$413M.

$MMSIMedAI 8/10

These Analysts Increase Their Forecasts On Merit Medical Systems After Strong Q2 Results - Merit Medical

Merit Medical Systems Inc (NASDAQ:MMSI) posted better-than-expected earnings for the second quarter on Thursday. The company posted adjusted EPS of $1.19, beating market estimates of 96 cents per share. The company’s sales came in at $418.843 million versus expectations of $405.268 million. Merit Medical Systems raised its FY2026 adjusted EPS guidance from $4.01-$4.15 to $4.25-$4.35 and increased its sales forecast from $1.612 billion-$1.634 billion to $1.631 billion-$1.643 billion.

$MMSIMedAI 8/10

Merit Medical Systems (NASDAQ:MMSI) Reports Bullish Q2 CY2026, Stock Soars

Medical device company Merit Medical Systems (NASDAQ: MMSI) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 9.5% year on year to $418.8 million. The company’s full-year revenue guidance of $1.64 billion at the midpoint came in 1.1% above analysts’ estimates. Its non-GAAP profit of $1.19 per share was 24% above analysts’ consensus estimates. Is now the time to buy Merit Medical Systems? Find out by accessing our full research report, it’s free.

$MMSIHigh

MERIT MEDICAL SYSTEMS INC (MMSI): Results of Operations and Financial Condition

MERIT MEDICAL SYSTEMS INC (MMSI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 mmsi-20260730xex99d1.htm EX-99.1 Exhibit 99.1 ​ ​ ​ ​ ​ ​ ​ ​ Contacts: ​ ​ ​ ​ PR/Media Inquiries: Sarah Comstock Merit Medical Investor Inquiries: Mike Piccinino, CFA, IRC ICR Healthcare ​ ​ +1-801-432-2864 +1-443-213-0509 ​ ​ sarah.comstock@merit.com mike.piccinino@i

$SHOPMedAI 8/10

Shopify Was Supposed to Be an AI Casualty. Its AI-Referred Traffic Just Tripled.

Shopify (SHOP) reported Q2 results, citing AI-referred traffic to merchants’ storefronts that tripled year over year and orders that began with AI search also tripled. New buyers from AI channels placed orders at nearly twice the rate of other channels. Revenue rose 34% to $3.6B, GMV reached $115.6B, operating income rose 68% to $488M, and free cash flow was $654M.